(openPR) The worldwide drug of abuse testing market (DOA) is expected to value at $3.9 billion in 2020. Two main drivers leading to growth of drug of abuse market are a significant increase in the use of illicit drugs and rising need for drug testing at organizational level. The market is expected to grow at a CAGR of 5.3% during 2015 to 2020. North America, the largest market by size in the drugs of abuse testing, is expected to grow at a CAGR of 5.8% during 2015 to 2020.
Explore detailed TOC and Scope of the report: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing
Several countries in America and Europe are using drug screening tests at various organizational levels, such as on the spot drug/alcohol screening, pre-employment screening, post incident drug/alcohol screening and abstinence monitoring. Government regulations in these countries are also supporting the growth of drugs abuse testing market, mainly through practice of drug testing at workplace. The number of strategic collaborations, mergers and acquisitions in the drug of abuse testing market is increasing globally for enhancing the quality, performance and portfolio of products.
Enquiry Before Purchase: https://www.psmarketresearch.com/enquiry-form.php?enqid=116&title=Enquiry%20before%20purchase
A major factor leading to the rise of drug of abuse testing has been the increased use of illicit drugs. The use of illicit drugs is rising every year globally and has become a big concern for countries including the U.S., the U.K. Japan, Germany, India and China. A major key challenge faced by the drug of abuse testing market is the failure to spot designer drugs such as LSD, Rohypnol and ecstasy.
Drug of abuse testing market can be segmented into two categories based on type of tests; laboratory based drugs of abuse tests and onsite drugs of abuse tests. The North American laboratory as well as onsite testing market has increased with more than 5.0% CAGR over the period 2011 to 2014, with onsite market standing at double the size of the laboratory testing market. The most common samples used for onsite testing are urine, saliva and hair. Nowadays, commercially available onsite drugs of abuse screening test kits are usually designed for urine and saliva specimens.
With North America being the largest region for drug of abuse testing, Europe comes second. In Europe, onsite testing had a market size of $346.1 million in 2014 and it is expected to grow at a faster rate than laboratory testing market during the period 2015 to 2020.
The major companies operating in the drug of abuse testing market include Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere, Inc., Abbott Laboratories, Randox laboratories, Psychemedics Corporation, Bio-Rad Laboratories, Sonic Healthcare and Thermo Fisher Scientific.
Request For Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=116&title=Report%20sample
Drug of Abuse Testing Market segmentation
Drug of Abuse Testing Market by type of tests
• Onsite
• Laboratory
• Others
Drug of Abuse Testing Market by Sample
• Urine
• Hair
• Saliva
• Others
Geographical Segmentation
Drug of Abuse Testing Market by Region
• North America
o The U.S.
• Europe
o Germany
o France
o The U.K.
• Asia Pacific
o India
o China
o Japan
